BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2900301)

  • 1. Effect of butylated hydroxyanisole on hepatic glucuronidation and biliary excretion of drugs in mice.
    Gregus Z; Klaassen CD
    J Pharm Pharmacol; 1988 Apr; 40(4):237-42. PubMed ID: 2900301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of butylated hydroxyanisole on hepatic glucuronidation capacity in mice.
    Hazelton GA; Hjelle JJ; Klaassen CD
    Toxicol Appl Pharmacol; 1985 Apr; 78(2):280-90. PubMed ID: 3929427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of hepatic uridine diphosphoglucuronic acid decreases the biliary excretion of drugs.
    Gregus Z; Watkins JB; Thompson TN; Klaassen CD
    J Pharmacol Exp Ther; 1983 May; 225(2):256-62. PubMed ID: 6405026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of galactosamine-induced hepatic UDP-glucuronic acid depletion on acetaminophen elimination in rats. Dispositional differences between hepatically and extrahepatically formed glucuronides of acetaminophen and other chemicals.
    Gregus Z; Madhu C; Goon D; Klaassen CD
    Drug Metab Dispos; 1988; 16(4):527-33. PubMed ID: 2903018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of butylated hydroxyanisole on acetaminophen hepatotoxicity and glucuronidation in vivo.
    Hazelton GA; Hjelle JJ; Klaassen CD
    Toxicol Appl Pharmacol; 1986 May; 83(3):474-85. PubMed ID: 3085287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased UDP-glucuronosyltransferase activity and UDP-glucuronic acid concentration in the small intestine of butylated hydroxyanisole-treated mice.
    Hjelle JJ; Hazelton GA; Klaassen CD
    Drug Metab Dispos; 1985; 13(1):68-70. PubMed ID: 2858380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
    Watkins JB; Klaassen CD
    J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of microsomal enzyme inducers upon UDP-glucuronic acid concentration and UDP-glucuronosyltransferase activity in the rat intestine and liver.
    Goon D; Klaassen CD
    Toxicol Appl Pharmacol; 1992 Aug; 115(2):253-60. PubMed ID: 1386480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids.
    Zhong Z; Kauffman FC; Thurman RG
    Cancer Res; 1991 Sep; 51(17):4511-5. PubMed ID: 1908348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated.
    Howell SR; Hazelton GA; Klaassen CD
    J Pharmacol Exp Ther; 1986 Mar; 236(3):610-4. PubMed ID: 3081704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
    Watkins JB
    J Pharmacol Exp Ther; 1989 Aug; 250(2):421-7. PubMed ID: 2760837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute and chronic butylated hydroxyanisole administration on in vivo glucuronidation of N-nitrosobutyl(4-hydroxybutyl)amine in rats.
    Pastorelli R; Ancidei A; Fanelli R; Airoldi L
    Food Chem Toxicol; 1988 May; 26(5):419-23. PubMed ID: 3391464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary 2(3)-tert-butyl-4-hydroxyanisole on the metabolism and action of estradiol and estrone in female CD-1 mice.
    Zhu BT; Lech J; Rosen RT; Conney AH
    Cancer Res; 1997 Jun; 57(12):2419-27. PubMed ID: 9192820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
    Gregus Z; Madhu C; Klaassen CD
    Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of single-dose and repeated-dose pretreatment with 2(3)-tert-butyl-4-hydroxyanisole (BHA) on the hepatobiliary disposition and covalent binding to DNA of aflatoxin B1 in the rat.
    Monroe DH; Holeski CJ; Eaton DL
    Food Chem Toxicol; 1986 Dec; 24(12):1273-81. PubMed ID: 3100404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of several xenobiotics on the activities of enzymes affecting ascorbic acid synthesis in rats.
    Horio F; Kimura M; Yoshida A
    J Nutr Sci Vitaminol (Tokyo); 1983 Jun; 29(3):233-47. PubMed ID: 6137523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of UDP-glucuronic acid depletion by salicylamide on biliary bilirubin excretion in the rat.
    Kamisako T; Adachi Y; Yamamoto T
    J Pharmacol Exp Ther; 1990 Aug; 254(2):380-2. PubMed ID: 2384879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of uridine diphosphate glucuronosyltransferase expression by phenolic antioxidants.
    Kashfi K; Yang EK; Chowdhury JR; Chowdhury NR; Dannenberg AJ
    Cancer Res; 1994 Nov; 54(22):5856-9. PubMed ID: 7954414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronidation and excretion of nonylphenol in perfused rat liver.
    Daidoji T; Inoue H; Kato S; Yokota H
    Drug Metab Dispos; 2003 Aug; 31(8):993-8. PubMed ID: 12867487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choleresis and increased biliary efflux of glutathione induced by phenolic antioxidants in rats.
    Jaeschke H; Wendel A
    Toxicology; 1988 Nov; 52(3):225-35. PubMed ID: 3188036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.